Emergent Biosolutions Inc Share Price CINNOBER BOAT
Equities
0IGA
US29089Q1058
Pharmaceuticals
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.2 USD | 0.00% | 0.00% | 0.00% |
05-02 | Sector Update: Health Care Stocks Softer Late Afternoon | MT |
05-02 | Sector Update: Health Care | MT |
Sales 2024 * | 1.02B 79.79B | Sales 2025 * | 1.14B 89.41B | Capitalization | 328M 25.78B |
---|---|---|---|---|---|
Net income 2024 * | -155M -12.18B | Net income 2025 * | -110M -8.64B | EV / Sales 2024 * | 0.43 x |
Net Debt 2024 * | 111M 8.74B | Net Debt 2025 * | 336M 26.4B | EV / Sales 2025 * | 0.58 x |
P/E ratio 2024 * |
-2.09
x | P/E ratio 2025 * |
-2.97
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.38% |
Latest transcript on Emergent Biosolutions Inc
Managers | Title | Age | Since |
---|---|---|---|
Joseph Papa
CEO | Chief Executive Officer | 68 | 02-20 |
Richard Lindahl
DFI | Director of Finance/CFO | 70 | 25/03/18 |
Kelly Warfield
CTO | Chief Tech/Sci/R&D Officer | - | 16/03/23 |
Members of the board | Title | Age | Since |
---|---|---|---|
Keith Katkin
BRD | Director/Board Member | 52 | 31/03/22 |
Marvin White
BRD | Director/Board Member | 61 | 31/05/10 |
Louis Sullivan
BRD | Director/Board Member | 90 | 31/12/04 |
1st Jan change | Capi. | |
---|---|---|
+46.32% | 754B | |
+40.95% | 630B | |
-5.86% | 352B | |
+19.91% | 331B | |
+9.54% | 298B | |
+18.45% | 250B | |
+11.88% | 217B | |
-0.78% | 216B | |
+6.17% | 164B |
- Stock Market
- Equities
- EBS Stock
- 0IGA Stock